tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ZYME Stock Latest News

Zymeworks Sets Strategic Milestones for 2025-2026 with Focus on Novel Therapeutics
Company AnnouncementsZymeworks Sets Strategic Milestones for 2025-2026 with Focus on Novel Therapeutics
10d ago
ZYME
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
12d ago
BLRX
CLLS
Zymeworks price target raised to $14 from $12 at Wells Fargo
PremiumThe Fly
Zymeworks price target raised to $14 from $12 at Wells Fargo
1M ago
ZYME
Zymeworks upgraded to Overweight on 2025 pipeline at JPMorgan
PremiumThe Fly
Zymeworks upgraded to Overweight on 2025 pipeline at JPMorgan
1M ago
ZYME
Zymeworks upgraded to Overweight from Neutral at JPMorgan
PremiumThe Fly
Zymeworks upgraded to Overweight from Neutral at JPMorgan
1M ago
ZYME
Zymeworks Advances Oncology and Expands Therapeutic Reach
PremiumCompany AnnouncementsZymeworks Advances Oncology and Expands Therapeutic Reach
1M ago
ZYME
Zymeworks hosts R&D day highlighting continued clinical progress
Premium
The Fly
Zymeworks hosts R&D day highlighting continued clinical progress
1M ago
ZYME
Zymeworks to Showcase Innovations at Investor Conferences
Premium
Company Announcements
Zymeworks to Showcase Innovations at Investor Conferences
2M ago
ZYME
Zymeworks Secures FDA Approval for Ziihera
PremiumCompany Announcements
Zymeworks Secures FDA Approval for Ziihera
2M ago
ZYME
Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
PremiumThe Fly
Zymeworks, Jazz Pharmaceuticals announce FDA approval of Ziihera
2M ago
JAZZ
ZYME
JPMorgan, Five Below downgraded: Wall Street’s top analyst calls
PremiumThe Fly
JPMorgan, Five Below downgraded: Wall Street’s top analyst calls
2M ago
F
EIX
Zymeworks upgraded to Outperform from Market Perform at Leerink
PremiumThe Fly
Zymeworks upgraded to Outperform from Market Perform at Leerink
2M ago
JAZZ
ZYME
Zymeworks Launches Phase 1 Trial for ZW191
PremiumCompany AnnouncementsZymeworks Launches Phase 1 Trial for ZW191
2M ago
ZYME
Zymeworks says first patient dosed in Phase 1 trial of ZW191
Premium
The Fly
Zymeworks says first patient dosed in Phase 1 trial of ZW191
2M ago
ZYME
Zymeworks price target raised to $18 from $16 at Citi
Premium
The Fly
Zymeworks price target raised to $18 from $16 at Citi
3M ago
ZYME
Zymeworks’ Future Hinges on Developing Key Diagnostic Tests Amidst Regulatory Challenges
PremiumCompany Announcements
Zymeworks’ Future Hinges on Developing Key Diagnostic Tests Amidst Regulatory Challenges
3M ago
ZYME
PayPal, Estee Lauder downgraded: Wall Street’s top analyst calls
PremiumThe Fly
PayPal, Estee Lauder downgraded: Wall Street’s top analyst calls
3M ago
EL
BCC
Wells downgrades Zymeworks with zanidatamab approval priced in
PremiumThe Fly
Wells downgrades Zymeworks with zanidatamab approval priced in
3M ago
JAZZ
ZYME
Zymeworks downgraded to Equal Weight from Overweight at Wells Fargo
PremiumThe Fly
Zymeworks downgraded to Equal Weight from Overweight at Wells Fargo
3M ago
ZYME
Zymeworks Reports Q3 Results and Strategic Advances
PremiumCompany AnnouncementsZymeworks Reports Q3 Results and Strategic Advances
3M ago
ZYME
Zymeworks Advances Biotherapeutic Pipeline in 2024
Premium
Company Announcements
Zymeworks Advances Biotherapeutic Pipeline in 2024
3M ago
8K
ZYME
Zymeworks reports Q3 EPS (39c), consensus (40c)
Premium
The Fly
Zymeworks reports Q3 EPS (39c), consensus (40c)
3M ago
ZYME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >